ABG
RPID icon

Ally Bridge Group’s Rapid Micro Biosystems RPID Stock Holding History

Ally Bridge Group’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-403,284
Closed -$403K – 21
2023
Q2 		$403K Sell
403,284
-296,380
-42% -$300K 0.49% 17
2023
Q1 		$917K Hold
699,664
– – 1.2% 15
2022
Q4 		$791K Hold
699,664
– – 0.77% 26
2022
Q3 		$2.26M Hold
699,664
– – 1.49% 24
2022
Q2 		$3.01M Hold
699,664
– – 2.74% 18
2022
Q1 		$4.75M Buy
699,664
+261,704
+60% +$1.93M 3.52% 12
2021
Q4 		$4.66M Hold
437,960
– – 1.63% 25
2021
Q3 		$8.09M Buy
+437,960
New +$9.05M 2.65% 20

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return